References
- Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366:539-51. https://doi.org/10.1056/NEJMra1104650
- Li W, Chen Y, Sun ZP, Cai ZG, Li TT, Zhang L, et al. Clinicopathological characteristics of immunoglobulin G4-related sialadenitis. Arthritis Res Ther 2015;17:186. https://doi.org/10.1186/s13075-015-0698-y
- Quattrocchio G, Roccatello D. IgG4-related nephropathy. J Nephrol 2016;29:487-93. https://doi.org/10.1007/s40620-016-0279-4
- Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology 2002;105:9-19. https://doi.org/10.1046/j.0019-2805.2001.01341.x
- Bindon CI, Hale G, Bruggemann M, Waldmann H. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. J Exp Med 1988;168:127-42. https://doi.org/10.1084/jem.168.1.127
- Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-related disease. Annu Rev Pathol 2014;9:315-47. https://doi.org/10.1146/annurev-pathol-012513-104708
- Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH, et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis 2019;78:406-12. https://doi.org/10.1136/annrheumdis-2018-214603